Blood Irradiation Therapy - Cibinqo (Abrocitinib) Interaction

Interaction Details

Abrocitinib is classified as belonging to the following category: Anticoagulant/Antiplatelet Drugs

Preliminary clinical research suggests that blood irradiation therapy might reduce platelet aggregation. Case reports also suggest that blood irradiation therapy may be associated with an increased risk of nasal bleeding. Theoretically, blood irradiation therapy might increase the risk of bleeding when used concomitantly with anticoagulant/antiplatelet drugs.
Some of these drugs include aspirin, clopidogrel (Plavix), nonsteroidal anti-inflammatory drugs (NSAIDs) such as diclofenac (Voltaren, Cataflam, others), ibuprofen (Advil, Motrin, others), naproxen (Anaprox, Naprosyn, others), dalteparin (Fragmin), enoxaparin (Lovenox), heparin, warfarin (Coumadin), and others.

Interaction Rating

Likelihood of Occurrence

Interaction has been documented in animal or in lab research, or the interaction has been documented in humans but is limited to case reports or conflicting clinical research exists

References

• Marochkov AV, Doronin VA, Kravtsov NN. [Complications in ultraviolet irradiation of the blood]. Anesteziol Reanimatol 1990;(4):55-6.
• Subbotina LA, Radchenko SN, Golovkina OL, Bubeev IuA. [Hemoaggregation dynamics in human-operator during percutaneous laser blood irradiation]. Aviakosm Ekolog Med 2009;43(3):56-60.
• Ovcharova AP. [The quantum gravitational therapy of myocarditis]. Lik Sprava 1999;(3):95-7.

Interaction Details

Abrocitinib is classified as belonging to the following category: Immunosuppressants

Clinical research suggests that blood irradiation therapy may stimulate immune function in some patients. Theoretically, concurrent use of blood irradiation therapy might interfere with immunosuppressive therapy.
Immunosuppressant drugs include azathioprine (Imuran), basiliximab (Simulect), cyclosporine (Neoral, Sandimmune), daclizumab (Zenapax), muromonab-CD3 (OKT3, Orthoclone OKT3), mycophenolate (CellCept), tacrolimus (FK506, Prograf), sirolimus (Rapamune), prednisone (Deltasone, Orasone), and other corticosteroids (glucocorticoids).

Interaction Rating

Likelihood of Occurrence

Interaction has been documented in animal or in lab research, or the interaction has been documented in humans but is limited to case reports or conflicting clinical research exists

References

• Chepik EB, Shamanova MG, Medvedeva EV, et al. Photochemotherapy in the treatment of acute pneumonias]. Vestn Ross Akad Med Nauk 1994;(9):48-51.
• Tkachenko IuIa, Kovalenko NN, Kogosova LS, et al. [The clinico-immunological characteristics of bronchial asthma patients undergoing autologous ultraviolet blood irradiation]. Lik Sprava 1993;(8):59-62.
• Gorskova VA, Evmenov VF, Zaitseva TS, et al. [Effects of surgical intervention and intravascular irradiation of blood with helium-neon laser on the state humoral autoimmunity in oncological patients]. Khirurgiia (Mosk) 1991;(9):92-8.
• Xiao X, Chu X, Ni J. [Effect of intravascular laser irradiation of blood and traditional Chinese medical therapy on immune function in senile cerebral infarction patients of kidney deficiency type]. Zhongguo Zhong Xi Yi Jie He Za Zhi 2000;20(4):264-6.
• Nazarov IP, Popov AA, Mal'tseva MA, et al. [State of neuroendocrine systems and immunity in patients with burns]. Anesteziol Reanimatol 1994;(1):5-8.
• Neimark AI, Muzalevskaia NI. [Low-intensity laser radiation in preoperative preparation of patients with benign prostatic hyperplasia]. Urologiia 2000;(1):11-5.
• Chernushenko EF, Dziublik AI, Naida IV, et al. [Effects of intravascular laser irradiation of blood on the immune status of patients with bronchial obstructive diseases of the lungs]. Klin Med (Mosk) 1991;69(12):51-3.

Abrocitinib Overview

• Abrocitinib is used to treat moderate to severe eczema (atopic dermatitis; a skin disease that causes the skin to be dry and itchy and to sometimes develop red, scaly rashes) in adults and children 12 years of age and older who cannot use other medications for their condition or whose eczema has not responded to other medications. Abrocitinib is in a class of medications called Janus kinase (JAK) inhibitors. It works by decreasing the activity of the immune system.

Blood Irradiation Therapy - More Interactions

Blood Irradiation Therapy interacts with 315 drugs

Interaction Rating Key

These severity listings are for informational use only. Never start, stop or otherwise change your therapy before speaking with your provider.